novo 14 (Rybelsus 14 mg)
Generic Name: semaglutide
Pill with imprint novo 14 is White, Elliptical/Oval and has been identified as Rybelsus 14 mg. It is supplied by Novo Nordisk.
Rybelsus is used in the treatment of diabetes, type 2 and belongs to the drug class incretin mimetics. Rybelsus 14 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for novo 14
Rybelsus
- Generic Name
- semaglutide
- Imprint
- novo 14
- Strength
- 14 mg
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Incretin mimetics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novo Nordisk
- National Drug Code (NDC)
- 00169-4314
More about Rybelsus (semaglutide)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (133)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: incretin mimetics
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.